Skip to main content
. 2024 Mar 8;15:1274442. doi: 10.3389/fphar.2024.1274442

TABLE 6.

PRSresponse values in responders and non-responders and logistic multivariate regression analysis between PRSresponse and response to treatment.

N PRSresponse mean ± SD (range) Or (95%C.I.) P Sensitivity (%) Specificity (%) PPV (%) NPV (%) Cutoff
Responders Non-responders
All patients 460 6.15 ± 1.96 (1.99–11.91) 5.69 ± 1.92 (0.098–11.96) 1.14 (1.03–1.26) 0.01 63 58 64 57 5.66
SCZ, SA, BD 235 6.19 ± 1.79 (1.99–10.86) 5.60 ± 1.94 (0.098–11.96) 1.18 (1.02–1.37) 0.02 60 56 62 53 5.58
SCZ, SA 176 6.26 ± 1.77 (2.97–10.86) 5.52 ± 2.06 (0.098–11.96) 1.24 (1.04–1.47) 0.01 56 55 59 52 5.02
SCZ 149 6.13 ± 1.76 (2.97–10.86) 5.34 ± 1.90 (1.96–11.96) 1.27 (1.04–1.55) 0.01 62 61 66 57 5.02
SA 27 7.13 ± 1.67 (5.01–9.89) 6.32 ± 2.60 (0.098–9.03) 1.78 (0.91–3.52) 0.09 83 87 83 87 5.00
BD 59 6.02 ± 1.84 (2.00–10.75) 5.91 ± 1.47 (3.94–8.97) 1.00 (0.71–1.41) 0.98 86 29 64 58 5.33
Others 96 6.00 ± 2.08 (2.00–10.95) 5.96 ± 1.86 (1.97–9.93) 0.98 (0.76–1.26) 0.87 66 77 74 70 6.97

Results corrected for age PC1, PC2, PC3, PC4, PC5. SCZ, schizophrenia; SA, schizoaffective disorder; BD, bipolar disorder; Others include neurocognitive disorder, substance abuse disorder, depression, miscellaneous; N, number of patients; OR, odds ratio; 95%CI: 95% confidence interval; P, p-value, statistically significant results in bold; PC, genetic principal components; PPV, positive predictive value; NPV, negative predictive value; cutoff, empirical optimal cut-off value to separate responders and non-responders, calculated according to the Youden’s method.